IPO
-
-
-
-
-
-
-
NLS Pharmaceutics Announces Patent Issuance in the United States for its Mazindol Extended-Release Formulation
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

